Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

NCT06432036 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Stage I Renal Cell Cancer
Stage II Renal Cell Cancer

Interventions

PROCEDURE: Angiogram
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
RADIATION: Radioembolization
PROCEDURE: Single Photon Emission Computed Tomography
OTHER: Survey Administration
RADIATION: Yttrium Y 90 Glass Microspheres

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]